Veriheal

AUGUST 24, 2022

This campaign was backed by New Approach PAC, a nationwide political organization that is focused on supporting progressive reform surrounding cannabis and criminal justice policies. So much, in fact, that it actually gained the attention of the DEA , which recently called for an increase in psychedelic production for research purposes.

Legalization 108

Legalization Medicine Decriminalization Research and Development 108

Cannabis Law Report

FEBRUARY 28, 2022

Show More According to the Drug Enforcement Administration (DEA), Schedule I drugs have “no currently accepted medical use in the United States, a lack of accepted safety for use under medical supervision, and a high potential for abuse.” In 2017, the FDA designated MDMA a breakthrough therapy for PTSD. Feduccia et al., 19 × 19.

Research and Development 52

Research and Development Therapy Law Clinical Trials 52

Cannabis Law Report

SEPTEMBER 23, 2019

During the 20 th century, law enforcement and public policy activities have undermined opportunities for scientific exploration. Relevant AAFP Policy. Therefore, the AAFP advocates for further research into the overall safety and health effects of recreational use, as well as the effects of those laws on patient and societal health.

Cannabinoids 40

Cannabinoids Marijuana Research and Development Access 40

SpeedWeed

MARCH 18, 2021

Given the topical nature of the current trial and its relevance for public policy on medical cannabis, participants might have been biased to report positive effects regardless of condition. Wasn’t the DEA going to let others grow research-grade cannabis? It tested at only 9% THC. Bruce Kennedy. View original article.

Clinical Trials 40

Clinical Trials THC Strains Cannabis 40

Cannabis Law Report

JULY 14, 2021

Legislation opens doors for cannabis policy reform in the current Congress. Cory Booker (D-NJ) and Ron Wyden (D-OR), released draft legislation today that would remove cannabis from the schedule of controlled substances while allowing states to determine their own cannabis policies. WASHINGTON, D.C. Ganjapreneur. Marijuana Times.

Legislation 71

Legislation Banking History Access 71

CannaMD

SEPTEMBER 10, 2020

This creates a somewhat confusing landscape for mothers who might benefit from cannabis-based therapies, but are also concerned for the safety of their child and the very real possibility of institutional intervention when marijuana use during pregnancy is documented. But despite these revelations, both messaging and legalities have lagged.

Marijuana 59

Marijuana Therapy Data THC 59

Cannabis Law Report

DECEMBER 1, 2019

Barr stated, “I am not going to go after companies that have relied on the Cole memorandum,” referring to the 2013 Obama administration policy of not enforcing marijuana prohibition in states where legalization has been established. “To Nevertheless, during his confirmation hearing in January 2019, Attorney General William P. Comm’r (T.C.

Marijuana 59

Marijuana Business State Laws DEA 59

The Cannigma

SEPTEMBER 12, 2021

The safety of using these products however, is still unknown. Marijuana (defined in the US as any cannabis plant where THC>0.3%) is a schedule I drug according to the DEA and FDA. Rather, it was based on a policy that was created in the 1950s, before THC or CBD were isolated and before the endocannabinoid system was discovered.

THC 98

THC Research and Development Cannabinoids CBD 98

Cannabis Law Report

NOVEMBER 2, 2021

Testing for Safety: Are Impurities a Problem? Testing for Safety: Are Impurities a Problem? Based on our analysis, there are currently around 160 companies selling delta-8 THC products online, with more than 4,200 unique products for sale, including edibles, concentrates, vapes, flower, prerolls, tinctures, topicals and beverages.

THC 96

THC CBD Legalization Vaping 96

Cannabis Law Report

JUNE 1, 2021

33%. – Beverages, edibles, topicals. and vapes. 14%. – Beverages, edibles, topicals. and vapes. Drug Enforcement Administration (the “DEA”), the U.S. Canadian recreational cannabis. – Dry bud[8]. – – Oils and softgels8. 73%. – Excise taxes.

Data 95

Data Vaping Supply Chain Business 95

Cannabis Law Report

AUGUST 6, 2021

Beverages, edibles, topicals 7. and vapes. Beverages, edibles, topicals. and vapes. Drug Enforcement Administration (the “DEA”), the U.S. Other revenue adjustments 8. $(3.0). Excise taxes. Medical cannabis and other. – Oils and softgels. Excise taxes. $(1.4). state and federal law to U.S.

Vaping 105

Vaping Research and Development Data Business 105

Meadow

JULY 13, 2018

The panel covered a wide range of topics local regulators are currently dealing with, including reconciling local and state regulations, enforcement of illicit businesses, license caps, equity and diversity, delivery, onsite consumption, and, of course, taxes. Photo Credit: Kandid Kush. Photo Credit: Kandid Kush. Who is on your team?

Wellness and Beauty 40

Wellness and Beauty Consumption Policy Cannabis 40